Skip to main content
FQHC Talent

Cookie notice

Allow detailed analytics to improve the site?It's from us, Google and Vercel, and stays off until you accept. If you're signed in, it can link your visits across devices. Declining doesn't limit what you can use. Details & privacy.

Back to the news
Risk & Compliance

Tampa General sues Lilly over 340B cutoff as 72 lawmakers press HHS

Federal

Issue

340B drug pricingIn court

Next: · Amgen to request 340B visit claims data starting November 15

Tampa General Hospital sued Eli Lilly on July 2 after Lilly ended its 340B discounts on June 18 for not sharing claims data, Health News Florida reported. The complaint puts the loss at roughly $24.7 million a year, and 72 House members asked HHS to act.

No health center cutoff has been confirmed so far.

Key points

  • Lilly's cutoff took effect June 18 for covered entities that did not share in-house claims data, and so far only hospitals are reported cut off.
  • Tampa General's federal suit (M.D. Fla., July 2) puts a number on the damage: 25-50% higher Lilly drug costs, ~$24.7M/year per the complaint.
  • 72 bipartisan House members are pressing HHS and HRSA to act, and FQHCs that dispense Lilly drugs should confirm their claims-data status now.

Sources for this story

WUSF (Health News Florida); Essential Hospitals; BioPharma Dive

Part of

Sources for your board packet

This story's source plus 4 related stories and their sources, ready to print for your team or board.

Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.

More in Risk & Compliance

Cite this analysis

FQHC Talent. (2026, July 10). Tampa General sues Lilly over 340B cutoff as 72 lawmakers press HHS. Source: WUSF (Health News Florida); Essential Hospitals; BioPharma Dive. Retrieved November 11, 2026, from https://www.fqhctalent.com/intel/lilly-340b-termination-tampa-general-lawsuit-house-letter-july-2026